CHM chimeric therapeutics limited

There is no comparison as this is the first time a CDH17 CAR-T...

  1. 14,252 Posts.
    lightbulb Created with Sketch. 4256
    There is no comparison as this is the first time a CDH17 CAR-T has been applied. Compared to chemo or check point inhibitors such as IMU's HER2 vax Her-Vaxx the results look less than impressive. But when looking at how many failed therapies the 2 patients had to go through and that the life expectancy for stage 4 gastric types is most less than 6 months then it is a remarkable result, especially at the lowest dose. Watch the video from the webinar, she explained it well.

    That alone and the $4m grant would deserve a sp above 1c but the MAN killed the momentum right from the start. People, me included, had lined up to buy higher, well done Mr Chairman.

    1.2c average for 5 days, then raise at 1c using a RI. It would have been a complete uptake as confidence for a turnaround would have been signalled to the market.

    0.5c, a typical slab in holders and staff's face.

    Why? We had similar discussions at the 0.8c raise and it will happen again at the next, 0.1c raise.

    Hopper's strategy lines up with the one from Coles, "Down, Down, Down"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $12.99M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $949 312.2K

Buyers (Bids)

No. Vol. Price($)
70 67782438 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 91927011 27
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.